THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Closing Glance: Biotechnology ends mixed

Email|Print|Single Page| Text size +
July 7, 2008

NEW YORK—Shares of biotechnology companies closed mixed Monday as the broader market fell over a cautious economic outlook from a Federal Reserve official and the possibility of more troubles in the financial sector.

Here's how several key biotechnology stocks performed Monday:

Gilead Sciences Inc., up 58 cents to $51.67.

Amgen Inc., down 57 cents to $50.27.

Biogen Idec Inc., up 67 cents to $58.87.

Genentech Inc., down $2.01, or 2.6 percent, to $75.93.

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.